| HCPCS Code | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
J9044 - Injection, bortezomib, not otherwise specified, 0.1 mg |
0.1 MG | 19.303 | - | - | - | - | - | - | ||
J9045 - Injection, carboplatin, 50 mg |
50 MG | 2.479 | - | - | - | - | - | - | ||
J9047 - Injection, carfilzomib, 1 mg |
1 MG | 40.482 | - | - | - | - | - | - | ||
J9050 - Injection, carmustine, 100 mg |
100 MG | 1722.023 | - | - | - | - | - | - | ||
J9055 - Injection, cetuximab, 10 mg |
10 MG | 66.312 | - | - | - | - | - | - | ||
J9060 - Injection, cisplatin, powder or solution, 10 mg |
10 MG | 1.835 | - | - | - | - | - | - | ||
J9065 - Injection, cladribine, per 1 mg |
1 MG | 18.679 | - | - | - | - | - | - | ||
J9070 - Cyclophosphamide, 100 mg |
100 MG | 30.997 | - | - | - | - | - | - | ||
J9100 - Injection, cytarabine, 100 mg |
100 MG | 0.685 | - | - | - | - | - | - | ||
J9119 - Injection, cemiplimab-rwlc, 1 mg |
1 MG | 27.577 | - | - | - | - | - | - | ||
J9120 - Injection, dactinomycin, 0.5 mg |
0.5 MG | 942.717 | - | - | - | - | - | - | ||
J9130 - Dacarbazine, 100 mg |
100 MG | 4.301 | - | - | - | - | - | - | ||
J9144 - Injection, daratumumab, 10 mg and hyaluronidase-fihj |
10 MG | 45.138 | - | - | - | - | - | - | ||
J9145 - Injection, daratumumab, 10 mg |
10 MG | 57.636 | - | - | - | - | - | - | ||
J9150 - Injection, daunorubicin, 10 mg |
10 MG | 45.242 | - | - | - | - | - | - | ||
J9153 - Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
1 MG/2.27 MG | 202.809 | - | - | - | - | - | - | ||
J9155 - Injection, degarelix, 1 mg |
1 MG | 3.983 | - | - | - | - | - | - | ||
J9171 - Injection, docetaxel, 1 mg |
1 MG | 0.537 | - | - | - | - | - | - | ||
J9173 - Injection, durvalumab, 10 mg |
10 MG | 76.756 | - | - | - | - | - | - | ||
J9176 - Injection, elotuzumab, 1 mg |
1 MG | 6.772 | - | - | - | - | - | - | ||
J9177 - Injection, enfortumab vedotin-ejfv, 0.25 mg |
0.25 MG | 29.063 | - | - | - | - | - | - | ||
J9178 - Injection, epirubicin hcl, 2 mg |
2 MG | 1.668 | - | - | - | - | - | - | ||
J9179 - Injection, eribulin mesylate, 0.1 mg |
0.1 MG | 121.287 | - | - | - | - | - | - | ||
J9181 - Injection, etoposide, 10 mg |
10 MG | 0.711 | - | - | - | - | - | - | ||
J9185 - Injection, fludarabine phosphate, 50 mg |
50 MG | 94.5 | - | - | - | - | - | - | ||
| * Effective Jul 1, 2021 through Sep 30, 2021 | ||||||||||
Medicare Part B payment allowance limits for drugs not otherwise classified - Effective Jul 1, 2021 through Sep 30, 2021
| Drug name | Dosage | Payment limit | Notes |
|---|---|---|---|
| Alfentanil Hcl | 500 MCG | 1.932 | |
| Allopurinol Sodium | 500 MG | 3320.364 | |
| Aminocaproic acid | 250 MG | 0.293 | |
| Aztreonam | 500 MG | 14.167 | |
| Bumetanide | 0.25 MG | 0.281 | |
| Bupivacaine | 1 ML | 0.089 | |
| Clindamycin Phosphate | 150 MG | 0.824 | |
| Coagulation Factor IX, Recombinant (Ixinity) | 1 IU | 2.21 | includes clotting factor furnishing fee |
| Diltiazem Hydrochloride | 5 MG | 0.294 | |
| Doxycycline Hyclate | 100 MG | 19.079 | |
| Esmolol Hydrochloride | 10 MG | 0.312 | |
| Famotidine | 10 MG | 0.432 | |
| Flumazenil | 0.1 MG | 0.793 | |
| Folic Acid | 5 MG | 2.919 | |
| Glucarpidase | 10 UNITS | 345.308 | |
| Glycopyrrolate injection | 0.2 MG | 2.317 | |
| Immune Globulin (Cutaquig) | 100 MG | 13.394 | |
| Immune Globulin (Panzyga) | 500 MG | 62.968 | |
| Labetalol Hcl | 5 MG | 0.126 | |
| Metoprolol Tartrate | 1 MG | 0.141 | |
| Metronidazole inj | 500 MG | 1.138 | |
| Nitroglycerin | 5 MG | 1.28 | |
| Olanzapine short acting intramuscular injection | 0.5 MG | 1.282 | |
| Paliperidone Palmitate (Invega Trinza) | 1 MG | 10.524 | |
| Rabies Immune Globulin (Kedrab) | 150 IU | 243.784 | |
| Rifampin | 600 MG | 106.951 | |
| Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.481 | |
| Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.581 | |
| Vasopressin | 20 UNITS | 210.415 |
AMP-based payment limit